Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Pre-market, Multi-center Evaluation of the Clinical Outcomes of the Insignia Hip Stem in Total Hip Arthroplasty (THA)

NCT06108934 is registered in ClinicalTrials.gov with Stryker Australia Pty Ltd. as lead sponsor.

NCT NCT06108934
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06108934 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Pre-market, Multi-center Evaluation of the Clinical Outcomes of the Insignia Hip Stem in Total Hip Arthroplasty (THA)
Lead sponsor
Stryker Australia Pty Ltd.
Phase
Not applicable
Overall status
Recruiting
Start date
February 22, 2024
Completion date
December 31, 2028
Enrollment
313 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis (e.g., degenerative joint disease (djd), osteoarthritis, and rheumatoid arthritis (ra))